Market Exclusive

Analyst Activity – Mizuho Reiterates Buy on NASDAQ:ADMS – Adamas Pharmaceuticals (NASDAQ:ADMS)

Analyst Ratings For NASDAQ:ADMS – Adamas Pharmaceuticals (NASDAQ:ADMS)

Today, Mizuho reiterated its Buy rating on NASDAQ:ADMS – Adamas Pharmaceuticals (NASDAQ:ADMS) with a price target of $49.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:ADMS – Adamas Pharmaceuticals (NASDAQ:ADMS)
NASDAQ:ADMS – Adamas Pharmaceuticals (NASDAQ:ADMS) has insider ownership of 29.00% and institutional ownership of 77.33%.

Recent Trading Activity for NASDAQ:ADMS – Adamas Pharmaceuticals (NASDAQ:ADMS)
Shares of NASDAQ:ADMS – Adamas Pharmaceuticals closed the previous trading session at 27.52 down -0.15 0.54% with 27.100000381469727 shares trading hands.

Exit mobile version